DCF — SANFORD CHAMBERLAIN MEDICAL CENTER
Enterprise Value: $-41.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-41.5M
Enterprise Value
$-13.1M
PV of Cash Flows
$-28.5M
PV of Terminal Value
$-45.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $24.4M | $-2.6M | -11.0% | $-3.6M | $-3.3M |
| Year 2 | $25.1M | $-2.4M | -10.0% | $-3.5M | $-2.9M |
| Year 3 | $25.8M | $-2.3M | -9.0% | $-3.4M | $-2.5M |
| Year 4 | $26.6M | $-2.2M | -8.0% | $-3.3M | $-2.3M |
| Year 5 | $27.4M | $-2.2M | -8.0% | $-3.4M | $-2.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-41.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$23.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11253254440422786
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5